Skip to main content
SpringerLink
Log in

Managing atrial fibrillation after coronary artery bypass graft surgery involves prophylaxis, cardioversion and/or ventricular rate control

  • Disease Management
  • Published:
Drugs & Therapy Perspectives Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III

References

  1. Hilleman DE, Hunter CB, Mohiuddin SM, et al. Pharmacological management of atrial fibrillation following cardiac surgery. Am J Cardiovasc Drugs 2005; 5(6): 361–9

    Article  PubMed  CAS  Google Scholar 

  2. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation 1996; 94(3): 390–7

    Article  PubMed  CAS  Google Scholar 

  3. Mathew JP, Parks R, Savino JS, et al. Atrial fibrillation following coronary artery bypass graft surgery: predictors, outcomes, and resource utilization. MultiCenter Study of Perioperative Ischemia Research Group. JAMA 1996; 276(4): 300–6

    Article  PubMed  CAS  Google Scholar 

  4. Lauer MS, Eagle KA, Buckley MJ, et al. Atrial fibrillation following coronary artery bypass surgery. Prog Cardiovasc Dis 1989; 31: 367–78

    Article  PubMed  CAS  Google Scholar 

  5. Rubin DA, Nieminski KE, Reed GE, et al. Predictors, prevention, and long-term prognosis of atrial fibrillation after coronary artery bypass graft operations. J Thorac Cardiovasc Surg 1987; 94: 331–5

    PubMed  CAS  Google Scholar 

  6. Lee JK, Klein GJ, Krahn AD, et al. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study. Am Heart J 2000; 140: 871–7

    Article  PubMed  CAS  Google Scholar 

  7. Fuller JA, Adams GC, Buxton B. Atrial fibrillation after coronary artery bypass grafting: is it a disorder of the elderly? J Thorac Cardiovas Surg 1989; 97: 821–5

    CAS  Google Scholar 

  8. Stamou SC, Hill PC, Dangas G, et al. Stroke after coronary artery bypass: incidence, predictors, and clinical outcome. Stroke 2001; 32: 1508–13

    Article  PubMed  CAS  Google Scholar 

  9. Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993; 56(3): 539–49

    Article  PubMed  CAS  Google Scholar 

  10. Hravnak M, Hoffman LA, Saul MI, et al. Resource utilization related to atrial fibrillation after coronary artery bypass grafting. Am J Crit Care 2002; 11: 228–38

    PubMed  Google Scholar 

  11. Weintraub WS, Becker ER, Mauldin PD, et al. Costs of revascularization over eight years in the randomized and eligible patients in the Emory Angioplasty versus Surgery Trial (EAST). Am J Cardiol 2000; 86: 747–52

    Article  PubMed  CAS  Google Scholar 

  12. Doering LV, Esmailian F, Laks H. Perioperative predictors of ICU and hospital costs in coronary artery bypass graft surgery. Chest 2000; 118: 736–43

    Article  PubMed  CAS  Google Scholar 

  13. Andrews TC, Reimold SC, Berlin JA, et al. Prevention of supraventricular arrhythmias after coronary artery bypass surgery: a meta-analysis of randomized control trials. Circulation 1991; 84Suppl. III: 236–44

    Google Scholar 

  14. Crystal E, Garfinkle MS, Connolly SS, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev 2004 Oct 18; (4): CD003611

    PubMed  Google Scholar 

  15. Kowey PR, Taylor JE, Rials SJ, et al. Meta-analysis of the effectiveness of prophylactic drug therapy in preventing supraventricular arrhythmia early after coronary artery bypass grafting. Am J Cardiol 1992; 69: 963–5

    Article  PubMed  CAS  Google Scholar 

  16. Miller S, Crystal E, Garfinkle M, Lau C, et al. Effects of magnesium on atrial fibrillation after cardiac surgery: a meta-analysis. Heart 2005; 91(5): 618–23

    Article  PubMed  CAS  Google Scholar 

  17. Martinez EA, Epstein AE, Bass EB, et al. Pharmacologic control of ventricular rate: American College of Chest Physicians guidelines for the prevention and management of postoperative atrial fibrillation after cardiac surgery. Chest 2005 Aug; 128(2 Suppl.): 56S–60S

    Article  PubMed  CAS  Google Scholar 

  18. Pfisterer ME, Kloter-Weber UC, Huber M, et al. Prevention of supraventricular tachyarrhythmias after open heart operation by low-dose sotalol: a prospective, double-blind, randomized, placebo-controlled study. Ann Thorac Surg 1997; 64: 1113–9

    Article  PubMed  CAS  Google Scholar 

  19. Forlani S, De Paulis R, de Notaris S, et al. Combination of sotalol and magnesium prevents atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg 2002; 74: 720–6

    Article  PubMed  Google Scholar 

  20. Gomes JA, Ip J, Santoni-Rugin F, et al. Oral d, l sotalol reduces the incidence of postoperative atrial fibrillation in coronary artery bypass surgery patients: a randomized, double-blind, placebo-controlled study. J Am Coll Cardiol 1999; 34: 334–9

    Article  PubMed  CAS  Google Scholar 

  21. Mooss AN, Wurdeman RL, Sugimoto JT, et al. Amiodarone versus sotalol for the treatment of atrial fibrillation after open heart surgery: the Reduction in Postoperative Cardiovascular Arrhythmic Events (REDUCE) trial. Am Heart J 2004; 148(4): 641–8

    Article  PubMed  CAS  Google Scholar 

  22. Tisdale JE, Padhi ID, Goldberg AD, et al. A randomized, double-blind comparison of intravenous diltiazem and digoxin for atrial fibrillation after coronary artery bypass surgery. Am Heart J 1998; 135: 739–47

    Article  PubMed  CAS  Google Scholar 

  23. Hilleman DE, Reyes AP, Mooss AN, et al. Esmolol versus diltiazem in atrial fibrillation following coronary artery bypass graft surgery. Curr Med Res Opin 2003; 19: 376–82

    Article  PubMed  CAS  Google Scholar 

  24. Olshansky B. Management of atrial fibrillation after coronary artery bypass graft surgery. Am J Cardiol 1996; 78: 27–34

    Article  PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Managing atrial fibrillation after coronary artery bypass graft surgery involves prophylaxis, cardioversion and/or ventricular rate control. Drugs Ther. Perspect 22, 12–15 (2006). https://doi.org/10.2165/00042310-200622090-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00042310-200622090-00004

Search

Navigation